Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

No cookies to display.

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

No cookies to display.

Skip to main content
search

The webinar titled “Oral Nicotine, Most Effective Tool in Tobacco Control?” highlighted the success Sweden has had with Snus and oral nicotine pouches in keeping smoking rates and oral cancers at an all-time low.

An all-star panel of global public health experts came together in a hybrid event (click here) on 30th November to highlight the success that Sweden has achieved in reducing smoking rates to just 5%, and ensuring the lowest lung, oral, larynx, heart disease, stroke and COPD rates amongst men in Europe. 

The panel also discussed the world-wide issues with the regulation and acceptance of snus and oral nicotine products, and discussed opportunities and practical ideas for how individuals, orginsations and governments can create change through simple incentive schemes. Dr. Delon Human mentioned that if we applied the same principles and practices that governments used during the covid19 pandemic, we could save many lives in tobacco control through the acceptance and risk-proportionate regulation of snus and oral nicotine products. (Click here to keep up to date with the Swedish twitter campaign.)

The panel featured the following:

Dr. Derek Yach – Physician and global consultant.

Professor Mihaela Răescu – Dentist and oral health expert. 

Professor Karl Fagerström – Psychologist and inventor of the Fagerström Test for Nicotine Dependence, which is a standard instrument for assessing the intensity of physical addiction to nicotine.

Dr. Anders Milton – Physician with extensive experience in public service, a highly sought-after consultant in the healthcare sector and a former chair of the World Medical Association (WMA).

Professor Solomon Rataemane – Professor of Psychiatry and expert in mood disorders.

Joseph Magero – Public policy professional and Chairman of Campaign for Safer Alternatives. 

Lars Ramström – Former Director of the Institute for Tobacco Studies and oral nicotine / snus expert.

Dr Delon Human – Physician and global public health consultant.

Dr. Kgosi Letlape – Ophthalmologist and health care leader from South Africa.

To read the latest press release from the event click here

To read more about the oral nicotine commission and snus, click here

THR IN AFRICA

Related Posts

Harm Reduction AfricaNicotine PouchesTHR in AfricaVapingLetter to the World Health Organization (WHO)
27 October 2021

Letter to the World Health Organization (WHO)

Letter to the World Health Organization (WHO) and delegates of the Ninth Conference of Parties (COP9) regarding the Framework Convention…
Oral NicotineVapingPublic Health implications of vaping in Germany
21 November 2021

Public Health implications of vaping in Germany

Prof Levy’s SAVM model predicts 4.7 million life-years saved, and 300,000 deaths avoided by 2060 In Germany’s population of 84…
Vaping Health Implications USADrug Harm ReductionVapingPublic Health implications of vaping in the United States of America
26 November 2021

Public Health implications of vaping in the United States of America

Public health implications of vaping in USA: Prof Levy’s SAVM model predicts 38.9 million life-years saved, and 1.8 million deaths…
Alcohol Harm Reduction

More about

Alcohol Harm Reduction

Drug Harm Reduction

More about

Drug Harm Reduction